Opportunity
DIBBS #SPE2DP-27-T-0127
DLA request for 3 bottles of moxifloxacin hydrochloride tablets
Posted
October 20, 2026
Respond By
October 26, 2026
Identifier
SPE2DP-27-T-0127
NAICS
424210
DLA Troop Support is seeking three bottles of moxifloxacin hydrochloride tablets for delivery to a U.S. Navy ship. - Government buyer: Defense Logistics Agency (DLA), DLA Troop Support, Medical Supply Chain Pharm FSA. - Requested product: 3 bottles of moxifloxacin hydrochloride tablets, 400 mg, with 30 tablets per bottle; NSN 6505-01-503-4772. - Approved manufacturers and source part numbers: - Rising Pharma Holdings, Inc. — NDC57237-0156-30. - Teva Pharmaceuticals USA, Inc. — NDC00093-7387-56. - These are alternative approved sources for the same quantity, not separate quantities. - Delivery and handling: FOB destination to USS Lewis B. Puller ESB 3; store at controlled room temperature and protect from high humidity. - Product requirement: FDA-regulated drug with a 36-month, non-extendable shelf life.
Description
MOXIFLOXACIN HYDROCHLO (QTY: 3, NSN: 6505-01-503-4772, Purchase Request: 7018767577) Approved Sources: - CAGE: 3V8D7, Part No: NDC00093-7387-56, Company: TEVA PHARMACEUTICALS USA, INC. - CAGE: 8FG82, Part No: NDC57237-0156-30, Company: RISING PHARMA HOLDINGS, INC.